International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company (MISX:GEMA) a acquis une participation de 6,93% dans la Public Joint-Stock Company "Human Stem Cells Institute" (MISX:ISKJ) le 15 mars 2022. L'International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company (MISX:GEMA) a achevé l'acquisition de 6,93% des parts de la Public Joint-Stock Company "Human Stem Cells Institute" (MISX:ISKJ) le 15 mars 2022.